KOC: A New Tumor Marker for Pancreatic Cancer
Author Information
Author(s): Mueller F, Bommer M, Lacher U, Ruhland C, Stagge V, Adler G, Gress T M, Seufferlein T
Primary Institution: University of Ulm, Germany
Hypothesis
KOC expression can serve as a diagnostic marker for pancreatic cancer.
Conclusion
The KOC assay shows high sensitivity and specificity for detecting malignant cells in fine-needle aspirates.
Supporting Evidence
- KOC transcripts were detected in 93% of malignant cases.
- The KOC assay showed 100% sensitivity in detecting malignant cells in cerebrospinal fluid.
- Diagnostic specificity of the KOC assay was 83% in FNAs.
- KOC expression was found in a broad spectrum of malignant cells.
- Initial cytological assessments were indeterminate in some cases but KOC was still detected.
Takeaway
KOC is a special marker that helps doctors find cancer in patients' samples, making it easier to diagnose.
Methodology
The study involved measuring KOC expression in fine-needle aspirates from patients and comparing it to cytological assessments.
Potential Biases
Potential bias in cytological assessments as they were performed independently.
Limitations
The study had a small sample size and some patients were not available for follow-up.
Participant Demographics
48 patients (20 women and 28 men) with a median age of 62.5 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website